Want to see what happens when a PAF candidate and a Belgian company are brought together?
Multinational
UCB
UCB is a global biopharmaceutical company focused on severe diseases in neurology and immunology. Founded in Belgium in 1928, UCB employs over 8,700 people across 36 countries, driven by a deep commitment to scientific innovation and patient-centered care.
“We were extremely lucky and grateful to have a candidate like Sofie. She accepted every challenge which was presented to her whilst bringing a positive atmosphere to the office. Sofie’s attitude and presence brought positive energy to the office on a daily basis. This contributed to building our team’s cohesive and productive culture. Her strong performance led to a permanent role at UCB HQ, where she now leads marketing for Evenity in Belgium and Luxembourg.”
SME
Equine Care Group
Founded in 2021, the Equine Care Group has become Europe’s leading provider of premium equine healthcare through specialized clinics, ambulatory care, and nutrition/supplement brands. With a vision to deliver the best possible medical care for horses, ECG fosters international partnerships and knowledge exchange to raise the standard of veterinary medicine worldwide.
“Angélique went above and beyond in her work for Equine Care Group. Her preparation and orchestration of key meetings across the US gave us the focus we needed. Since the PAF project ended, we have engaged Angélique permanently to continue the work she started. We are grateful to have found such a strong collaborator to help build ECG’s future. Thank you, Angélique. Thank you, PAF!”
Scale-up
Decontex Holding NV
Decontex (DCX) is an innovative Belgian scale-up that has developed a unique, patented,and sustainable solution for the full decontamination and disinfection of personal protective clothing. It serves operational government services (especially firefighters, alongside police and defense), as well as the heavy industry and medical sectors.
“Kelly’s project to develop and expand Decontex’s business in Brazil was a success. Despite the challenges of entering a new market—and her atypical background in medicine—Kelly made remarkable progress in raising awareness of Decontex’s services among potential partners and end-users. She concluded her PAF project by securing a key partnership, enabling Decontex to enter the market and establish a strategic presence for 2025.”
